1. Home
  2. ALAR vs FHTX Comparison

ALAR vs FHTX Comparison

Compare ALAR & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALAR
  • FHTX
  • Stock Information
  • Founded
  • ALAR 2013
  • FHTX 2015
  • Country
  • ALAR Israel
  • FHTX United States
  • Employees
  • ALAR N/A
  • FHTX N/A
  • Industry
  • ALAR Computer Software: Prepackaged Software
  • FHTX Medicinal Chemicals and Botanical Products
  • Sector
  • ALAR Technology
  • FHTX Health Care
  • Exchange
  • ALAR Nasdaq
  • FHTX Nasdaq
  • Market Cap
  • ALAR 200.6M
  • FHTX 310.9M
  • IPO Year
  • ALAR 2018
  • FHTX 2020
  • Fundamental
  • Price
  • ALAR $26.95
  • FHTX $5.90
  • Analyst Decision
  • ALAR Buy
  • FHTX Buy
  • Analyst Count
  • ALAR 2
  • FHTX 3
  • Target Price
  • ALAR $32.50
  • FHTX $13.00
  • AVG Volume (30 Days)
  • ALAR 745.1K
  • FHTX 143.7K
  • Earning Date
  • ALAR 08-22-2024
  • FHTX 08-02-2024
  • Dividend Yield
  • ALAR N/A
  • FHTX N/A
  • EPS Growth
  • ALAR N/A
  • FHTX N/A
  • EPS
  • ALAR N/A
  • FHTX N/A
  • Revenue
  • ALAR $29,218,000.00
  • FHTX $33,896,000.00
  • Revenue This Year
  • ALAR $41.21
  • FHTX N/A
  • Revenue Next Year
  • ALAR $25.00
  • FHTX $8.63
  • P/E Ratio
  • ALAR N/A
  • FHTX N/A
  • Revenue Growth
  • ALAR 43.58
  • FHTX 64.41
  • 52 Week Low
  • ALAR $2.07
  • FHTX $2.70
  • 52 Week High
  • ALAR $46.69
  • FHTX $9.97
  • Technical
  • Relative Strength Index (RSI)
  • ALAR 38.60
  • FHTX 51.91
  • Support Level
  • ALAR $26.62
  • FHTX $5.62
  • Resistance Level
  • ALAR $46.00
  • FHTX $6.98
  • Average True Range (ATR)
  • ALAR 3.89
  • FHTX 0.58
  • MACD
  • ALAR -1.68
  • FHTX 0.09
  • Stochastic Oscillator
  • ALAR 1.64
  • FHTX 51.13

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: